110 related articles for article (PubMed ID: 2294819)
1. Haemophilus influenzae diphtheria protein conjugate immunization after therapy in splenectomized patients with Hodgkin disease.
Jakacki R; Luery N; McVerry P; Lange B
Ann Intern Med; 1990 Jan; 112(2):143-4. PubMed ID: 2294819
[No Abstract] [Full Text] [Related]
2. Conjugated Haemophilus influenzae type b vaccine.
Med Lett Drugs Ther; 1988 Apr; 30(764):47-8. PubMed ID: 3258400
[No Abstract] [Full Text] [Related]
3. American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccine.
Pediatrics; 1988 Jun; 81(6):908-11. PubMed ID: 3259309
[No Abstract] [Full Text] [Related]
4. Update: prevention of Haemophilus influenzae type b disease.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1988 Jan; 37(2):13-6. PubMed ID: 3122004
[No Abstract] [Full Text] [Related]
5. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
Sood SK; Daum RS
Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
[TBL] [Abstract][Full Text] [Related]
6. Immune response of young children vaccinated with Haemophilus influenzae type b conjugate vaccines.
Madore DV; Phipps DC; Eby R; Johnson CL; Smith DH
Contrib Microbiol Immunol; 1989; 10():125-50. PubMed ID: 2684505
[No Abstract] [Full Text] [Related]
7. Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in vaccinated children who developed Haemophilus disease.
Weinberg GA; Murphy TV; Granoff DM
Pediatrics; 1990 Oct; 86(4):617-20. PubMed ID: 2216629
[No Abstract] [Full Text] [Related]
8. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.
Eskola J; Peltola H; Takala AK; Käyhty H; Hakulinen M; Karanko V; Kela E; Rekola P; Rönnberg PR; Samuelson JS
N Engl J Med; 1987 Sep; 317(12):717-22. PubMed ID: 3306379
[TBL] [Abstract][Full Text] [Related]
9. Safety, immunogenicity, and efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b vaccine in a United States population: possible implications for optimal use.
Black SB; Shinefield HR; Fireman B; Hiatt R
J Infect Dis; 1992 Jun; 165 Suppl 1():S139-43. PubMed ID: 1588149
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the Haemophilus influenzae type b conjugate vaccine PRP-D.
Robbins JB; Schneerson R
N Engl J Med; 1990 Nov; 323(20):1415-6. PubMed ID: 2233910
[No Abstract] [Full Text] [Related]
11. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in children with congenital asplenia.
Webber SA; Sandor GG; Patterson MW; Mitchell LA; Scheifele D; Ochnio JJ; McVerry PH
J Infect Dis; 1993 May; 167(5):1210-2. PubMed ID: 8486956
[TBL] [Abstract][Full Text] [Related]
12. High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines.
Käyhty H; Eskola J; Peltola H; Saarinen L; Mäkelä PH
J Infect Dis; 1992 Jun; 165 Suppl 1():S165-6. PubMed ID: 1588156
[No Abstract] [Full Text] [Related]
13. Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children.
CMAJ; 1993 Jan; 148(2):199-214. PubMed ID: 8452591
[No Abstract] [Full Text] [Related]
14. Finnish efficacy trials with Haemophilus influenzae type b vaccines.
Eskola J; Peltola H; Käyhty H; Takala AK; Mäkelä PH
J Infect Dis; 1992 Jun; 165 Suppl 1():S137-8. PubMed ID: 1588148
[TBL] [Abstract][Full Text] [Related]
15. Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection.
Steinhoff MC; Auerbach BS; Nelson KE; Vlahov D; Becker RL; Graham NM; Schwartz DH; Lucas AH; Chaisson RE
N Engl J Med; 1991 Dec; 325(26):1837-42. PubMed ID: 1683682
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine (PRP-D) in infants.
Lepow ML; Barkin RM; Berkowitz CD; Brunell PA; James D; Meier K; Ward J; Zahradnik JM; Samuelson J; McVerry PH
J Infect Dis; 1987 Oct; 156(4):591-6. PubMed ID: 3497990
[TBL] [Abstract][Full Text] [Related]
17. Haemophilus influenzae type b vaccine.
Anderson P; Pichichero ME
Pediatrics; 1989 Jan; 83(1):145-6. PubMed ID: 2909967
[No Abstract] [Full Text] [Related]
18. Immunogenicity of a new Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB).
Vella PP; Staub JM; Armstrong J; Dolan KT; Rusk CM; Szymanski S; Greer WE; Marburg S; Kniskern PJ; Schofield TL
Pediatrics; 1990 Apr; 85(4 Pt 2):668-75. PubMed ID: 2107517
[TBL] [Abstract][Full Text] [Related]
19. Post-marketing surveillance of adverse events following ProHIBit vaccine--British Columbia.
Meekison W; Hutcheon M; Guasparini R; Arnott M; Scheifele D; Grace M; Humphreys G; Barreto L
Can Dis Wkly Rep; 1989 Jul; 15(28):143-5. PubMed ID: 2791073
[No Abstract] [Full Text] [Related]
20. Haemophilus b oligosaccharide-CRM197 and other Haemophilus b conjugate vaccines: a status report.
Smith DH; Madore DV; Eby RJ; Anderson PW; Insel RA; Johnson CL
Adv Exp Med Biol; 1989; 251():65-82. PubMed ID: 2692432
[No Abstract] [Full Text] [Related]
[Next] [New Search]
